All lobbying filings

BALLARD PARTNERS

BALLARD PARTNERS filed a Q4 termination report for APOTEX CORP. on January 19, 2026, reporting $80,000 in lobbying income.

Lobbying for APOTEX CORP. · Pharmaceutical manufacturer

All filings by BALLARD PARTNERS · Everything APOTEX CORP. has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Florida

Representation ended

Nov 30, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

HUNTER MORGEN

Previously held: Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Manufacturing

Advice and guidance related to supply chains and trade tariffs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.